Cell membrane‐coated nanoparticles for dermatological diseases
VIEW, Volume 7, Issue 3, June 2026.Skin disorders are challenging to treat due to complex barrier functions and limited conventional therapies. Biomimetic cell membrane‐coated nanoparticles (CM‐NPs) offer a superior nanomedicine approach by evading immune detection and enabling precise targeting.
Shuaijun Zou, Baojie Zhang, Yuanjie Zhu
wiley +1 more source
The role of leishmania proteophosphoglycans in sand fly transmission and infection of the Mammalian host. [PDF]
, 2012 Leishmania are transmitted by the bite of their sand fly vector and this has a significant influence on the virulence of the resulting infection. From our studies into the interaction between parasite, vector, and host we have uncovered an important ...
Rogers, Matthew E +2 more
core +1 more source
Mini-Exon Genotyping of Leishmania Species in Khuzestan Province, Southwest Iran [PDF]
Iranian Journal of Parasitology, 2010 Background: Leishmaniasis is a protozoan disease cause by Leishmania genus. Anthroponotic and zoonotic cutaneous leishmaniasis are endemic in Iran. The aim of this study was to identify the causative agent of cutaneous leishmaniasis by mini-exon gene in
J Saki +7 more
doaj +1 more source
The ecology and control of cutaneous Leishmaniasis vectors in the sub-Andean mountainous zone of Huila department, Colombia [PDF]
This thesis describes a series of studies designed to improve our understanding of the transmission cycle of cutaneous leishmaniasis (CL) in the coffee-growing sub-Andean region of Huila department and to explore the use of ...
Pardo Puentes, Raul Hernando
core +1 more source
A Declining Trend of 'Leishmaniasis' Based on Previous Data in Larstan, South of Iran 2007–2017
Annals of Global Health, 2019 Introduction: 'Cutaneous Leishmaniasis' is a unicellular of the Leishmania type, and 0.7 to 1.2 million people are annually infected by 'Cutaneous Leishmaniasis'. Larestan is one of the southern cities of Fars Province.
Ahmad Abolghazi +4 more
doaj +1 more source
Visceral leishmaniasis in eastern Africa--current status. [PDF]
, 2007 Visceral leishmaniasis (VL) is among the most neglected of the tropical diseases, afflicting the poorest of the poor. In eastern Africa, VL causes at least 4000 deaths annually, a loss of approximately 385,000 disability-adjusted life years.
Reithinger, Richard +3 more
core +1 more source
Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Acta Medica Iranica, 2019 The human T cell lymphotropic virus type-1 (HTLV-1) is associated with adult T cell leukemia/lymphoma (ATL) and other disorders, including a slowly progressive demyelinating paraparesis, known as HTLV-1-associated myelopathy/tropical spastic paraparesis (
Reza Boostani +8 more
doaj
Prevalence of Leishmania spp. infection in domestic dogs in Chapare, Bolivia. [PDF]
, 2011 Data on Leishmania spp. infection in dogs in Bolivia is scarce. Dogs from an area where 90% of human cutaneous leishmaniasis (CL) cases are due to Leishmania (Viannia) braziliensis were screened for Leishmania infection using established enzyme-linked ...
Reithinger, Richard +11 more
core +1 more source
Evaluation of first generation vaccines against human leishmaniasis and the implication of Leishmanin Skin Test (LST) response in disease prevalence [PDF]
, 2011 This study reports the detailed analysis of the data from ten different clinical trials of first generation prophylactic vaccines (FGV) against leishmaniasis.
Noazin, Sassan
core +1 more source
Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran
Case Reports in Infectious Diseases, 2015 Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where
Mohammadali Davarpanah +2 more
doaj +1 more source